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    Endometriosis is a painful reproductive disease afflicting about up to 20% of women. It is one of the 
most frequent benign gynaecological diseases, however, little is known about the pathological of 
endometriosis. Over the past decade, high-throughput proteomics technologies have evolved 
considerably and have become increasingly more commonly applied to the investigation of female 
reproductive disease, including endometriosis. In this mini-review the authors look at the application of 
proteomics technologies in order to find biomarker associated with endometriosis. 
 
Keyword: Endometriosis; Proteomics; Diagnosis 
 
INTRODUCTION 
Endometriosis is a gynecological pathogenesis 
manifested by the growth of endometrial glands 
and stroma outside the uterine cavity. 
Endometriosis is mostly observed in the fertility 
years and it is only rarely observed in adolescent 
and postmenopausal women. The common cause 
of endometriosis is pain symptoms 
(dysmenorrhea, dyspareumia, chronic pelvic pain) 
and infertility [1] . Women with endometriosis is 
estimated to be 4-19%, however, endometriosis is 
more frequently observed in women with pain 
symptoms and infertility [2, 3]. 
Pathogenesis of endometriosis 
The etiology of endometriosis remains a mystery. 
Several theories about pathogenesis of 
endometriosis have been suggested. The most 
accepted one is Sampsons's theory. This theory 
believes that the disease originated from 
retrograde menstruation of viable endometrial 
tissue through the fallopian tubes into the 
peritoneal cavity, where it implants on the 
peritoneal surface of pelvic organs. However, 
retrograde menstruation occurs almost in all 
women and it does not explain presence of 
endometriosis in the remote areas such as the 
lungs, skin, and breast. Another theory suggest 
that endometriosis is due to the occurrence of 
celomic metaplasia in the pelvic peritoneum [4]. 
Most recently, adult stem cell has been suggested 
that is the cause of endometriosis. It is suggested 
that adult stem cells reside in the basalis. Since 
the endometrium comprises glands, surface 
epithelium and supportive stroma, it is 
hypothesized that both epithelial and stromal 
stem/progenitor cells are responsible for the 
regenerative capacity of endometrium [5]. 
Proteome definition 
The proteome has been defined as the protein 
complement of the genome. However, the 
definition of proteome has changed since its first 
defined by Wilkins et al. in 1995 [6]. Today, the 
term of proteome has developed to be: "The 
proteome of an individual is defined by the sum 
and the time dynamics of all protein species 
occurring during the life-time of this individual ". 
This definition of the proteome includes the 
protein expression of the individual protein, the 
isoforms of a protein and post-translational 
modifications of a protein [7].  
Proteomics technologies 
The first proteome analysis goes back to 1975, 
although the proteome was not defined at that 
moment. Protein separation and comparison by 




two-dimensional gel electrophoresis (2-DE) is the 
classical method for quantitative analysis of the 
proteome [8]. Klose [9] and O‟Farrell [10] first 
described the technique in 1975. The major 
advantage of 2-DE lies in its potential to 
simultaneously resolve thousands of proteins, at 
the same time revealing their MW, pI, and 
reflecting changes in protein expression and 
isoforms [11]. Apart from these advantages, 2-DE 
has also some drawbacks. One of its limitations 
includes the difficulty identification of low (<15 
kDa) and high (>150 kDa) molecular weight of 
proteins and separation is generally limited to 
proteins that are neither too acidic/basic, nor too 
hydrophobic. A further limitation of traditional 2-
DE is time-consuming and labor-intensive. In 
addition, the lack of reproducibility between gels 
leads to significant system variability making it 
difficult to distinguish between system variations 
and induced biological change, which means that 
real differences between protein abundance 
attributed. 
To overcome some of the shortcomings of the 
above approaches non-gel-based quantitative 
proteomics methods have been developed 
significantly in recent years. The development of 
gel free proteomic techniques such as 
Multidimensional Protein Identification 
(MudPIT) has provided powerful tools for 
studying large scale protein expression and 
characterization in complex biological systems 
[12, 13]. This approach was first described by 
Link et al. [14]. The technique consists of a 2-D 
LC peptide separation. A protein mixture is 
digested using proteolytic enzyme, such as 
trypsin. The resulting peptides are then separated 
by multidimensional LC coupled to mass 
spectrometry. First, the peptide mixtures are 
separated by strong cation exchange (SCX, first 
dimension). It is then followed by reverse-phase 
(RP, second dimension) separation coupled to 
electrospary mass spectrometer (ESI-MS/MS) 
[14]. MudPIT not only overcomes the 
shortcomings of 2-DE but also provides the 
following advantages: elimination of the time-
consuming step for protein separation; high 
sensitivity and requirement of small sample size; 
and versatile mechanisms for peptide separation. 
A major disadvantage of MudPIT is an inability 
to readily provide information on protein isoforms 
or posttranslational modifications [15]. 
Another gel-free proteomic technique based on 
the principle of diagonal 
electrophoresis/chromatography is combined 
fractional diagonal chromatography 
(COFRADIC). Briefly, whole proteome digests 
are first separated by RP-HPLC into distinct 
fractions. Each primary fraction or a combination 
thereof is then treated with an enzyme or a 
chemical compound modifying the structure of a 
selected class of peptides. This modification 
reaction is chosen such that peptides holding such 
modified structures are differently retained by 
chromatographic columns. Thus, when such 
modified primary fractions are separated a second 
time under identical chromatographic conditions 
as during the primary separation, they separate 
from non-modified peptides and are isolated for 
LC-MS/MS analysis [16]. COFRADIC method 
has been used to isolate N-terminal, methionyl 
peptides etc. from whole proteome digests [17, 
18]. The main disadvantage of the COFRADIC 
technology compared with the 2-DE approach is 
the lack of information regarding the pI of the 
proteins identified, which would miss relevant 
information about potential PTMs. However, both 
methods complement each other, and thus 
COFRADIC allowed the identification of several 
membrane-spanning proteins not previously 
identified by 2-DE, demonstrating that gel-free 
methods are able to overcome some of the 
limitations of the 2-DE approach [19]. 
One way to determine quantification of proteins is 
difference gel electrophoresis (DIGE). Due to the 
limitations of 2-DE that mentioned above Unlu et 
al. [20] first described a method, 2-DE DIGE, that 
enabled more than one sample to be separated in a 
single 2-DE. The development of 2-DE DIGE 
gives more accurate and reliable quantification 
information of protein abundance because the 
samples to be compared are run together on the 
same gel, eliminating potential gel-to-gel 
variation. However, spots on a given 2-DE often 
contain more than one protein, making 
quantification ambiguous since it is not 
immediately apparent which protein in the spot 
has changed. In addition, any 2-DE approach is 
subject to the restrictions imposed by the gel 
method [21].  
A number of stable isotope labeling approaches 
have been developed for “shot-gun” quantitative 
proteomic analysis. These are divided into two 




categories: in vivo (metabolic labeling) and in 
vitro (enzymatic or chemical labeling) [22]. The 
stable isotope labeling methods have provided 
valuable flexibility while using quantitative 
proteomic techniques to study protein changes in 
complex samples. However, most labeling-based 
quantification approaches have potential 
limitations. These include increased time and 
complexity of sample preparation, requirement 
for higher sample concentration, high cost of the 
reagents, incomplete labeling, and the 
requirement for specific quantification software 
[23]. 
Metabolic or in vivo labeling involves the 
incorporation of stable isotopes during protein 
biosynthesis [24]. Initially described for total 
labeling of bacteria using 15N-enriched cell 
culture medium it has gained wider popularity in 
the form of the stable isotope labeling by amino 
acids in cell culture (SILAC) approach introduced 
by Mann and co-workers in 2002 [25, 26]. The 
SILAC technique relies on the incorporation of 
isotopically labeled amino acids into proteins 
formed by the growing organism. Isotopically 
labeled amino acids are usually added to the 
growth medium or the labeled amino acids can be 
generated by the organism through the addition of 
isotopically labeled salts to the growth medium 
[25-27]. The advantages of SILAC are that it has 
higher fidelity than ICAT (incorporating nearly 
100% efficiency) and does not require multiple 
chemical processing and purification steps, thus 
ensuring that the samples to be compared have 
been subjected to similar conditions throughout 
the experiment. However, This approach requires 
viable active cell lines to allow for the 
incorporation of the respective heavy/ light amino 
acids into the protein samples and may not always 
be available for all experimental samples [28]. 
Post-labeling of proteins and peptides is 
performed by chemical or enzymatic 
derivatization in vitro. The first in vitro labeling 
the ICAT (Isotope Coded Affinity Tags) approach 
developed by Reudi Aebersold and et al. [29]. 
Because cysteine is a rare amino acid, ICAT and 
related methods significantly reduce the 
complexity of the peptide mixture which can be 
advantageous when highly complex samples are 
analyzed. In addition, as it is a solution-phase 
labeling, those proteins not amenable to 2-DE, 
such as very acidic/ basic, too large/small proteins 
can now be analyzed using an LC-MS workflow. 
However, ICAT is obviously not suitable for 
quantifying the significant number of proteins that 
do not contain any (or a few) cysteine residues 
and is of limited use for analysis of post-
translational modifications and splice isoforms 
[30]. One limitation of ICAT is that there are only 
two labels available. This could results in multiple 
experiments if more than two treatments need to 
be compared, and would increase the cost 
accordingly. The need for comparisons of larger 
numbers of treatments led to the development of 
the 4-or 8-plex iTRAQ, which can compare up to 
four or eight samples in a single analysis, 
respectively. The iTRAQ technique was first 
described by Ross et al. in 2004 [31]. The iTRAQ 
label is an isobaric tagging compound consisting 
of a reporter group (variable mass of 4-plex: 114–
117 Da or 8-plex: 113–121 Da), a balance group 
and an amino-reactive group that introduces a 
highly basic group at lysine side chains and at 
peptide N-terminal (Fig. 1). During the initial MS 
scan, labeled peptides appear as a single peak due 
to the isobaric masses. The isobaric nature of 
iTRAQ-labeled peptides allows the signal from 
all peptides to be summed in both MS and 
MS/MS modes thus enhancing the sensitivity of 
detection. During MS/MS, the label releases the 
reporter group as a singly charged ion of masses 
at m/z 114–117 (4- plex) or m/z 113-121 (8-plex) 
[22]. The advantages of iTRAQ are to identify 
and quantify low-abundance proteins in complex 
samples – coupled with the ability to multiplex up 
to eight samples in parallel suggests that iTRAQ 
and similar mass balanced labels holds the most 
promise for quantitative biomarker discovery 
[32]. A primary computerized search was 
performed in PubMed of publications for 
quantative proteomics. Figure 2 show the number 
of publications per year using various types of 
quantitative proteomics up to 2010. Although it 
was impossible to select „key words‟ to include 
every relevant publication, it was clear that all of 
the methods described above are still in use. 
Moreover, with the possible exception of ICAT, 
the use of most of these methods is increasing 
each year.  





Figure 1. Workflow the labeling and analysis of samples by iTRAQ. 
 
 
In fact, the numbers of publications using DIGE, 
iTRAQ methods are all increasing at 
approximately equal rate. Surface-enhanced laser 
desorption/ionization (SELDI-MS) uses 
chemically defined or antibody-coated protein 
biochip arrays for rapid protein detection. An 
advantage of SELDI-TOF-MS is its relatively 
high tolerance for salts and other impurities. The 
sample requirement is low (1–10 μg total protein 
per spot) and sample volume can be freely chosen 
from 0.5 μl up to around 400 μl. However, it is 
incompatible with TOF MS/MS and does not 
allow reliable protein identification [33-35]. 
 
 
Figure 2. Trends in mass-spectrometry based quantification. Publications per year (up to 2010), based on a keyword search in NCBI. 




Application of proteomics technologies 
for the study of endometriosis 
Over the past decade, high-throughput proteomics 
technologies have been developed rapidly and 
have become increasingly more commonly 
applied to the investigation of endometriosis. 
Proteomics technology enables comparison of 
hundreds or thousands of proteins to identify 
disease-specific biomarkers.  
The discovery of novel candidate biomarkers is 
one of crucial problems for the early diagnosis of 
endometriosis. In the area of biomarker discovery, 
proteomic techniques are proving particularly 
powerful tools to identify protein in blood or 
tissues that may be markers of disease. New 
classes of biomarkers derived from mass 
spectroscopy analysis of the low molecular 
weight proteome have shown improved abilities 
in the early detection of disease and hence in 
patient risk stratification and outcome. This 
review mainly presents current advances in the 
problems and prospects of candidate biomarker 
for the early diagnosis of endometriosis, 
discovered by technologies of proteomics. To our 
knowledge, only several studies have been 
published in which 2DE-PAGE was applied to the 
analysis of serum, endometrium, peritoneal fluid 
and endometrial fluid from women with 
endometriosis, with some promising preliminary 
findings of differential protein expression 
 between diseased and nondiseased subjects (is 
explained below).  
Zhang et al. [36] compared the protein expression 
maps of eutopic endometria and sera of women 
with or without endometriosis using two-
dimensional gel electrophoresis. After the 
comparative proteomic study, they have identified 
13 and 11 differentially expressed proteins in sera 
and eutopic endometrium between the two study 
groups, respectively. These proteins were 
characterized by searching a computerized 
database using molecular weight and isoelectric 
points, but some of sera proteins remain elusive. 
Some of the matched proteins with different 
expression may be cytoskeletons, and others may 
be the regulatory proteins of cell cycle, signal 
transduction, or immunological function. Those 
proteins include the G antigen family B1 protein, 
actin-related protein 6, actinlike-7- anhydrase I, 
Dentin matrix acidic phosphoprotein I, CD166 
antigen, cyclin A1, and 14-3-3 protein sigma et al. 
Another group used 2D-PAGE for the 
Comparison of protein expression during both the 
secretory and proliferative phase eutopic 
endometrium from women with and without 
endometriosis [37]. They identified dysregulated 
proteins in women with endometriosis which 
included: molecular chaperones including heat 
shock protein 90 and annexin A2, proteins 
involved in cellular redox state, such as 
peroxiredoxin 2, proteins involved in protein and  
DNA formation/breakdown, including 
ribonucleoside-diphosphate reductase, prohibitin 
and prolyl 4-hydroxylase, and secreted proteins, 
such as apolipoprotein A1. 
Have and colleagues [38] studied eutopic 
endometrium in women with endometriosis, using 
2DE-PAGE. A total of 820 protein spots were 
matched on 2-D gels, with 119 proteins regulated 
differentially between the two study groups. Of 
the 50 highest fold change proteins 21 proteins 
were found only in the endometriosis affected 
sample group. The authors observed that several 
molecules were up- and down-regulated in several 
areas including apoptosis, immune reaction, 
glycolytic pathway, cell structure, and 
transcription factors.  
In one study applied proteomic techniques to the 
analysis of peritoneal fluid (PF) proteome in 
fertile and infertile women with endometriosis, 
the investigators used 2-DE to analyze the PF of 
patients. A total of 114 protein spots were 
presented in PF of fertile and infertile women 
with endometriosis. Nine protein spots had 
significantly higher expression in PF of infertile 
women when compared with fertile controls with 
endometriosis. These proteins were identified as 1 
isoform of α-1-antitrypsin, 2 isoforms of 
serotransferrin, 1 isoform of complement C3, 1 
isoform of serum amyloid P-component and 1 
isoform of clusterin. Three protein spots remain 
unidentified. Abnormalities in the immune 
response have been hypothesized to be involved 
in the pathophysiology of endometriosis 
associated infertility [39]. 
Ametzazurra et al. were described the use of 
endometrial fluid aspirate from the uterine cavity 
of women as a biological sample for the discovery 
of biomarkers associated with endometriosis. 
Samples were collected during the post-ovulatory 




secretory phase of the menstrual cycle. They have 
used 2-DE to examine endometrial fluid. 
Endometrial fluid exhibits a complex and rich 
proteome composition with more than 800 protein 
spots detected. The changes in protein expression 
observed in this comparison have predominantly 
identified proteins involved in cell signalling, cell 
death and cell movement. Among the 
differentially expressed proteins Ametzazurra et 
al. found a high representation of cytoskeletal 
proteins, such as moesin, beta-actin, tubulin beta 
chain, F-actin capping protein subunit beta, WD 
repeat protein 1, heat-shock protein beta-1 and 
septin-11. Also, Levels of 14-3-3 protein sigma 
and gamma  (signal transduction) were 
significantly higher in the endometrial fluid 
aspirate of women suffering from endometriosis 
[40]. Other studies utilized SELDI-TOF-MS 
technology as a proteomic tool in discovering 
proteins that are differentially expressed in 
women with and without endometriosis [41-49]. 
But, as mentioned above SELDI does not allow  
reliable protein identification. So this technique is 
not suitable for diagnosis of endometriosis.  
 
Future perspective 
Clinically engineered mass spectroscopy systems 
are essential for the further development and 
validation of multiplexed biomarkers that have 
shown tremendous promise for the early detection 
of disease. Future endometriosis research in the 
area of noninvasive diagnosis needs to be 
performed using endometriotic tissue, 
endometrium and peritoneal fluid in the quest to 
identify new biomarkers for this complex disease 
and increase understanding of the 
pathophysiology. Newer technologies such as gel 
free proteomic techniques like for example 
iTRAQ and iTRAQ combined MudPIT and 
proteomic pattern profiling should be explored in 
the area of development of a possible screening 
test for the disease. 
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